Travere Therapeutics, Inc.
SEC CIK 1438533 · TVTX · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Coughlin Timothy P | Director | filed 2015 - 2026 |
| Baynes Roy D. | Director | filed 2016 - 2026 |
| Lyons Gary A | Director | filed 2014 - 2026 |
| Williams Brinkley Ruth | Director | filed 2021 - 2026 |
| Squarer Ron | Director | filed 2017 - 2026 |
| Orwin John A | Director | filed 2017 - 2026 |
| Meckler Jeffrey A | Director | filed 2014 - 2026 |
| Bruhn Suzanne Louise | Director | filed 2020 - 2026 |
| Poole Sandra | Director | filed 2019 - 2026 |
| Dube Eric M | Director · Chief Executive Officer | filed 2019 - 2026 |
| Aselage Steve | Director · President and COO | filed 2013 - 2022 |
| Kozarich John W | Director | filed 2015 - 2019 |
| Golding Cornelius E | Director | filed 2013 - 2016 |
| Richardson Steven Gary | Director | filed 2013 - 2014 |
| Shkreli Martin | Director · Chief Executive Officer | filed 2012 - 2014 |
| Paley Jeffrey | Director | filed 2013 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Inrig Jula | Chief Medical Officer | filed 2022 - 2026 |
| Reed Elizabeth E | SVP, GC & Corporate Secretary | filed 2017 - 2026 |
| Rote William E. | Senior Vice President, R&D | filed 2017 - 2026 |
| Heerma Peter | Chief Commercial Officer | filed 2019 - 2026 |
| Cline Christopher R. | Chief Financial Officer | filed 2022 - 2026 |
| Calvin Sandra | VP, Corp Controller and CAO | filed 2021 - 2026 |
| Clague Laura | Chief Financial Officer | filed 2014 - 2022 |
| Rosenberg Noah L. | Chief Medical Officer | filed 2018 - 2021 |
| Mcfarlane Neil F. | Chief Operating Officer | filed 2016 - 2019 |
| Shih Alvin | EVP of Research & Development | filed 2014 - 2016 |
| Valeur Jensen Margaret E | General Counsel | filed 2014 - 2016 |
| Plotkin Horacio | Chief Medical Officer | filed 2013 - 2014 |
| Panoff Marc L | Chief Financial Officer | filed 2013 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.